METROPOLITAN HOSPITAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $843K
- Transactions
- 239
- Companies
- 19
- Average per transaction
- $3,527
Who reported the payments
| Sanofi US Services Inc. | $258,656 |
| Pfizer | $218,911 |
| Sanofi | $170,000 |
| Global Blood Therapeutics, Inc. | $127,543 |
| Tanabe Pharma America, Inc. | $20,700 |
| Regeneron | $12,650 |
| E.r. Squibb & Sons, L.L.C. | $10,000 |
| Biotronik Inc. | $5,050 |
| Astrazeneca UK Limited | $4,471 |
| Aesculap, Inc. | $4,355 |
| Kls-martin L.p. | $3,396 |
| Stryker | $2,548 |
| Olympus America Inc. | $1,905 |
| Zimmer Biomet | $1,276 |
| Hill-rom Holdings, Inc | $1,138 |
| Edwards Lifesciences | $282 |
| Johnson & Johnson | $96 |
| Hollister Incorporated | $40 |
| Genmark Diagnostics, Inc. | $26 |